Activity
-
This week on #BioTechNation, Catalyst Pharmaceuticals, Inc. CEO Rich Daly discusses why some medical conditions require multiple medications and why…
This week on #BioTechNation, Catalyst Pharmaceuticals, Inc. CEO Rich Daly discusses why some medical conditions require multiple medications and why…
Shared by Moira Gunn
-
This week on #BioTechNation, Ari Azhir shares how she reacquired an ALS drug after its phase two trial failure, uncovered critical flaws in the data,…
This week on #BioTechNation, Ari Azhir shares how she reacquired an ALS drug after its phase two trial failure, uncovered critical flaws in the data,…
Shared by Moira Gunn
-
This week on #BioTechNation, Daniel Kraft, MD shares how researchers are uncovering thousands of "dark" proteins in the human body. These newly…
This week on #BioTechNation, Daniel Kraft, MD shares how researchers are uncovering thousands of "dark" proteins in the human body. These newly…
Shared by Moira Gunn
More activity by Moira
-
This week on #BioTechNation, Lincoln Nadauld talks about Culmination Bio’s efforts to improve how we treat diseases. Using 9 million preserved…
This week on #BioTechNation, Lincoln Nadauld talks about Culmination Bio’s efforts to improve how we treat diseases. Using 9 million preserved…
Shared by Moira Gunn
-
This week on #BioTechNation, Daniel Kraft, MD explores why mobility is becoming a critical health metric. With wearable devices tracking movement, AI…
This week on #BioTechNation, Daniel Kraft, MD explores why mobility is becoming a critical health metric. With wearable devices tracking movement, AI…
Shared by Moira Gunn
-
This week on Biotech Nation, Dr. Martin Borch Jensen and Dr. Francisco LePort from Gordian Biotechnology discuss their innovative approach to…
This week on Biotech Nation, Dr. Martin Borch Jensen and Dr. Francisco LePort from Gordian Biotechnology discuss their innovative approach to…
Shared by Moira Gunn
-
This week on #BioTechNation, David Fajgenbaum, MD, MBA, MSc, cofounder of Every Cure, discusses their groundbreaking work in drug repurposing. Using…
This week on #BioTechNation, David Fajgenbaum, MD, MBA, MSc, cofounder of Every Cure, discusses their groundbreaking work in drug repurposing. Using…
Shared by Moira Gunn
-
This week on #BioTechNation, Benjamin Zimmer, CEO of Priovant Therapeutics, talks about their mission to improve the lives of patients with severe…
This week on #BioTechNation, Benjamin Zimmer, CEO of Priovant Therapeutics, talks about their mission to improve the lives of patients with severe…
Shared by Moira Gunn
-
This week on #BioTechNation, David Bearss Ph.D., President & CEO of Halia Therapeutics, Inc., joins me to talk about the fight against inflammation…
This week on #BioTechNation, David Bearss Ph.D., President & CEO of Halia Therapeutics, Inc., joins me to talk about the fight against inflammation…
Shared by Moira Gunn
-
This week on #BioTechNation, Dr. Jim Brown, President and CEO of DURECT Corporation, talks about a potential breakthrough treatment for…
This week on #BioTechNation, Dr. Jim Brown, President and CEO of DURECT Corporation, talks about a potential breakthrough treatment for…
Shared by Moira Gunn
-
This week on #BioTechNation, Sir Rory Collins, Principal Investigator of the UK Biobank, shares how half a million people are helping scientists…
This week on #BioTechNation, Sir Rory Collins, Principal Investigator of the UK Biobank, shares how half a million people are helping scientists…
Shared by Moira Gunn
-
This week on #BioTechNation, David Pacitti, MBA, President of Siemens Healthineers, joins me to discuss how they’re tackling some of healthcare’s…
This week on #BioTechNation, David Pacitti, MBA, President of Siemens Healthineers, joins me to discuss how they’re tackling some of healthcare’s…
Shared by Moira Gunn
-
Major Depressive Disorder. PTSD. Serious Depression. Dr. Amit Etkin, CEO of Alto Neuroscience, shares how they're transforming mental health care…
Major Depressive Disorder. PTSD. Serious Depression. Dr. Amit Etkin, CEO of Alto Neuroscience, shares how they're transforming mental health care…
Shared by Moira Gunn
-
This week on #BioTechNation, Dr. Vimal Mehta, CEO of BioXcel Therapeutics, Inc., joins me to discuss how AI is transforming drug discovery. From…
This week on #BioTechNation, Dr. Vimal Mehta, CEO of BioXcel Therapeutics, Inc., joins me to discuss how AI is transforming drug discovery. From…
Shared by Moira Gunn
-
This week on #BioTechNation, Daniel Kraft, MD, Tech Nation Health Chief Correspondent joins me to talk about the concept of “food as medicine.” From…
This week on #BioTechNation, Daniel Kraft, MD, Tech Nation Health Chief Correspondent joins me to talk about the concept of “food as medicine.” From…
Shared by Moira Gunn
-
This week on #BioTechNation, Peter Vanderklish, Chief Scientific Officer at Spinogenix, Inc. discusses their work in synapse regeneration. From…
This week on #BioTechNation, Peter Vanderklish, Chief Scientific Officer at Spinogenix, Inc. discusses their work in synapse regeneration. From…
Shared by Moira Gunn
-
This week on #BiotechNation, a first-time-ever test is being cleared for a deadly condition responsible for 1 in 5 deaths worldwide… Sepsis. Rollie…
This week on #BiotechNation, a first-time-ever test is being cleared for a deadly condition responsible for 1 in 5 deaths worldwide… Sepsis. Rollie…
Shared by Moira Gunn
-
This week on #BioTechNation, Anthropologist Eben Kirksey asks us to look at the societal and ethical implications of CRISPR – and not just…
This week on #BioTechNation, Anthropologist Eben Kirksey asks us to look at the societal and ethical implications of CRISPR – and not just…
Shared by Moira Gunn
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Moira Gunn
2 others named Moira Gunn are on LinkedIn
See others named Moira Gunn